Go Capital

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementary sectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Distinguin, Bertrand

Director of investment - General Manager

Jerome Gueret

Director of investment

Bruno Guicheux Ph.D

Investment Director

Ménard, Alexis

Partner

Leila Nicolas

Investment Director

125 past transactions

Reelevant

Series A in 2025
Reelevant is a company that specializes in hyper-personalized customer experience solutions, focusing on enhancing the last mile of customer interactions. Founded in 2016, Reelevant aims to reconnect brands with their customers by creating memorable brand moments and maximizing customer lifetime value (CLTV). The company achieves this by converting data into relevant content that is generated and synchronized in real time, tailored to each customer's specific context across all digital touchpoints. Reelevant's technology improves email marketing by collecting and analyzing a wide range of real-time data, enabling businesses to engage customers more effectively and accelerate revenue by delivering timely, relevant messages. The company has collaborated with various prominent brands, including Carrefour, Décathlon, L'Oréal, and Leroy Merlin.

BiOceanOr

Series A in 2025
BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.

Moea

Seed Round in 2025
Moea is a company which uses bio-materials from fruits and plants to create low-carbon and vegan sneakers

Sirius NeoSight

Seed Round in 2025
Sirius NeoSight is a biotechnology and pharmaceutical company focused on the early detection and treatment of subclinical neo-cancers. The company has developed innovative healthcare technology software that measures the fluidity of membranes specifically within the field of oncology. This patented technology is designed to enhance the detection and purification of Circulating Tumor Cells, contributing to advancements in personalized medicine. By addressing these critical aspects of cancer treatment, Sirius NeoSight aims to improve outcomes for patients through early intervention and tailored therapeutic approaches.

AISPRID

Series A in 2025
AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.

Uptale

Venture Round in 2024
Uptale is a company that offers an enterprise solution focused on improving employee learning through immersive experiences utilizing 360° and virtual reality technologies. Its platform enables organizations to create, share, and analyze training modules easily, without the need for technical expertise. By transforming various media into engaging learning experiences, Uptale allows users to access content on any device, both online and offline. The platform also includes features for maintaining security, confidentiality, and authentication, along with a data tracking dashboard that enhances the effectiveness of training programs. This comprehensive approach supports organizations in adopting more advanced cognitive services and technologies for employee development.

Lactips

Venture Round in 2024
Lactips specializes in the production of water-soluble and biodegradable thermoplastic pellets made from milk protein. Utilizing a proprietary industrial process, the company delivers these pellets in high volumes to serve as raw materials for various applications, including thermoforming and film production. Lactips aims to provide its industrial clients with innovative solutions that facilitate entry into new markets while promoting sustainability. Their products offer a cleaner alternative to traditional oil-based plastics, contributing to a more environmentally friendly approach to material use by enhancing dissolution in both hot and cold water.
Iadys designs, develops, and delivers robotic and AI innovations aimed at environmental preservation. The company's flagship product, the Jellyfishbot, is a robot that collects floating waste and oil in water bodies and performs underwater measurements. Iadys also offers the Mobile Oil Skimmer, which is used for oil spill response. These products are designed to access and clean hard-to-reach areas, contributing to cleaner and safer aquatic environments.

Brightflow

Series A in 2024
Brightflow operates as a medical device startup.

Dealt

Series A in 2024
Dealt is a service company focused on enhancing the retail and e-commerce customer experience through white-label solutions. It constructs, implements, and manages service offerings for businesses, allowing them to provide superior customer support and differentiate themselves from competitors. Dealt offers a comprehensive omnichannel solution that includes technological tools such as a service platform, APIs, and vendor solutions. Its extensive catalog features over 300 services at negotiated rates, supported by a national community of 10,000 certified professionals. The company has successfully completed over 40,000 service engagements and maintains a high customer satisfaction rating. Dealt has garnered recognition within the French retail ecosystem, winning multiple innovation awards in 2021 and being named start-up of the year at the "Connect Lille" event. It is backed by the Groupe La Poste and is trusted by several major retail brands.

Zest

Venture Round in 2024
Zest was founded on the realization that all businesses misuse their gold mine - their people. Zest is human resource management software for business employees.

United Visual Researchers

Venture Round in 2024
Predictive Solutions for Computer Aided Appearance Design CA²D.

Digital4better

Seed Round in 2024
Digital4better offers digital consulting and services aimed at enhancing the ecological and social performance of large organizations. The company focuses on developing IT applications and design operations that promote sustainable digital performance. By providing automated analysis and improvement solutions, Digital4better helps businesses assess and reduce their digital carbon footprint and improve accessibility. Their services also include a digital maturity framework, which assists organizations in evaluating and enhancing their digital capabilities. Overall, Digital4better is dedicated to driving performance and fostering sustainable practices in the digital landscape.

AVATAR MEDICAL

Seed Round in 2024
AVATAR MEDICAL specializes in developing a virtual reality platform that creates 3D patient avatars from medical images. This innovative technology assists surgeons in visualizing complex medical data, evaluating surgical options, and enhancing training for medical fellows. By providing accurate and interactive representations of patients, the platform enables clinicians to better comprehend critical clinical information, ultimately improving the decision-making process in surgical planning. Additionally, AVATAR MEDICAL's approach fosters greater engagement with patients, allowing them to better understand their medical conditions and treatment options.

Scalinx

Series B in 2024
Scalinx is a fabless semiconductor company that specializes in the design and supply of Signal Conversion ASICs and ASSPs for various markets, including Test & Measurement, MilAero, and Communications. The company operates from its headquarters in Paris, with additional design sites in Caen and Grenoble. In Caen, a team of 20 employees industrializes the designs before production is outsourced to a network of subcontractors. Scalinx focuses on developing semiconductor technology that enables wideband and low-power signal conversion, facilitating applications in wired and wireless communications, test and measurement equipment, and radar. This approach allows clients to reduce costs and shorten development time for signal conversion technologies.

Sweetch Energy

Series A in 2023
Sweetch Energy focuses on harnessing blue osmotic energy by utilizing advancements in nanotechnology and materials science. The company has developed a power harvesting technology that generates electricity by exploiting differences in water salinity through a filtration system. This innovative approach enables the production of electricity from saline gradients, providing consumers with access to affordable energy sources. By combining recent academic discoveries with practical applications, Sweetch Energy aims to offer a sustainable and cost-effective solution for electricity generation.

Biosency

Venture Round in 2023
Biosency is a medical device company based in Rennes, France, dedicated to developing innovative healthcare solutions. Its primary product is a connected PPG sensor system that offers a monitoring and prevention solution for respiratory insufficiency. This device provides continuous cardio-respiratory data, enabling healthcare professionals to prescribe respiratory assistance and manage home care effectively. By ensuring accurate measurement of patient compliance, Biosency's technology supports clinical management of respiratory diseases, ultimately enhancing patient care. The company collaborates closely with doctors and researchers to deliver advanced tools that benefit the medical community.

Loop Dee Science

Venture Round in 2023
Loop Dee Science is a DNA startup focused on molecular biology diagnostics, specializing in the development and manufacturing of field genetic analysis kits for detecting pathogen DNA and RNA. The company aims to make molecular diagnostics more accessible by utilizing amplification technology and creating tools that automate testing processes. Their automatic field analysis device is a multi-spectral analysis tool that offers local output and can connect via USB or Bluetooth, enhancing the user experience and enabling efficient pathogen detection in various environments.

Niryo

Series A in 2023
Niryo is a provider of educational robots intended to help in prototype industrial case studies.

Episto

Venture Round in 2023
Episto specializes in developing technologies that facilitate the collection of authentic opinions from diverse audiences. The company creates tailored social media advertisements designed to engage specific target groups and gather feedback through interactive questionnaires that resemble instant messaging formats. By employing hyper-targeted advertisements and conversational techniques on messaging platforms, Episto enables clients to foster genuine interactions with their customers. This approach not only enhances lead generation but also allows businesses to obtain valuable insights through various types of questions, including multiple-choice, open-ended, and media formats, thereby improving their ability to connect with current and prospective customers.

Abcely

Seed Round in 2023
Abcely is a biotechnology company focused on developing innovative medical and pharmaceutical technologies aimed at treating mucosal cancers. The firm is engaged in creating a novel anti-cancer medication that leverages a new concept of immunotherapy. By utilizing active therapeutic molecules, Abcely identifies compounds of biological origin that may serve as potential active ingredients. The company's approach is designed to enhance the effectiveness of cancer treatment, providing healthcare professionals with advanced tools to combat this disease in clinical settings.

Kanta

Seed Round in 2023
Kanta is a technology company that specializes in anti-money laundering (AML) solutions and accounting audit management. Its AML technology automates data gathering and processing to streamline compliance with regulatory standards, effectively managing monitoring activities that are often time-consuming. In addition, Kanta offers a platform designed for accounting firms that simplifies the management of ethical obligations. This platform aids in assessing risk levels, managing business relationships, and handling assignments. It further supports accounting professionals by centralizing official documents, importing customer portfolios, and providing comprehensive reports and dashboards. Through these offerings, Kanta enables small and medium-sized accounting firms to fulfill their due diligence requirements more efficiently.

BuyCo

Series A in 2023
BuyCo is a developer of global transportation management software aimed at addressing the challenges faced by shippers in managing complex shipping operations. The company's platform provides real-time visibility and control over shipments by consolidating container information that is often dispersed among various stakeholders. This integrated collaborative platform enables users to track current sailing schedules, monitor shipment status, and access essential updates, thereby enhancing communication and collaboration within the logistics network. By leveraging advanced technology and a robust partnership network, BuyCo helps logistics professionals improve delivery reliability, reduce transportation costs, and streamline overall operations, ultimately simplifying and securing the shipping process for its clients.

GenSensor

Seed Round in 2023
GenSensor is a genomic-based in-line bioproduction monitoring system. GenSensor combines the development of a robotic device with advanced analytics software to monitor, characterize, and optimize your bioproduction of ATMP and vaccines.

Expliseat

Venture Round in 2023
Expliseat is a manufacturer specializing in lightweight aircraft seats, most notably the Titanium Seat, which weighs only 4 kg. This innovative design significantly reduces fuel consumption, yielding potential savings of up to $500,000 per aircraft annually. The seats are crafted from carbon fiber and feature a unique hinge mechanism, ensuring durability while accommodating passengers of all sizes. With ten patents to its name, Expliseat's products also enhance passenger comfort by providing two additional inches of legroom, catering to the evolving needs of airlines and their customers.

Orosound

Private Equity Round in 2023
Orosound is a French startup focused on enhancing workplace well-being through innovative audio solutions. The company specializes in developing advanced Noise Control Technologies, particularly through its earphone brand, Tilde. These earphones incorporate noise-filtering technology that allows users to selectively filter out ambient noise, thereby minimizing distractions for office workers. By creating high-tech acoustic products, Orosound aims to improve the daily experiences of individuals in professional environments.

Ligerio

Seed Round in 2022
Ligerio is the benchmark for interior and exterior planning and decoration of cozy homes! Ligerio.fr is the promise to find on a single platform a wide and rigorously selected offer of materials and decorative elements.

Sweetch Energy

Seed Round in 2022
Sweetch Energy focuses on harnessing blue osmotic energy by utilizing advancements in nanotechnology and materials science. The company has developed a power harvesting technology that generates electricity by exploiting differences in water salinity through a filtration system. This innovative approach enables the production of electricity from saline gradients, providing consumers with access to affordable energy sources. By combining recent academic discoveries with practical applications, Sweetch Energy aims to offer a sustainable and cost-effective solution for electricity generation.

TRiCares

Series C in 2022
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.

Graftys

Venture Round in 2022
Graftys is an early-stage company based in Aix-en-Provence, France, specializing in advanced bone biologics. The company develops synthetic bone biomaterials specifically designed for reconstructive orthopedic surgery. Graftys offers a range of innovative and fully injectable calcium phosphate bone graft substitutes that are tailored for various clinical applications. By focusing on safety and quality, Graftys aims to provide effective solutions for patients undergoing bone reconstructive and trauma surgery.

Digital4better

Seed Round in 2022
Digital4better offers digital consulting and services aimed at enhancing the ecological and social performance of large organizations. The company focuses on developing IT applications and design operations that promote sustainable digital performance. By providing automated analysis and improvement solutions, Digital4better helps businesses assess and reduce their digital carbon footprint and improve accessibility. Their services also include a digital maturity framework, which assists organizations in evaluating and enhancing their digital capabilities. Overall, Digital4better is dedicated to driving performance and fostering sustainable practices in the digital landscape.

Healshape

Venture Round in 2022
Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women. The company specializes in regenerative medicine, focusing on creating innovative alternatives for breast regeneration through advanced 3D bioprinting technology. Healshape's primary product is a bioprosthesis designed for breast reconstruction, which aims to empower women by helping them regain self-confidence and achieve long-lasting, aesthetically pleasing results following surgery.

Pepette

Series A in 2022
Pepette specializes in providing high-quality food products and recipes for cats and dogs. The company offers a range of fresh, organic options including gourmet chicken, beef, and pollock fillets, all developed under the guidance of a veterinary nutritionist. By focusing on the nutritional needs of pets, Pepette ensures that customers receive tailored recipes designed to support the health and well-being of their animals.

SENSE in

Venture Round in 2022
SENSE in manufactures monitoring solutions based on thermomechanical sensors sensitive to deformation, pressure, temperature, humidity, and more. Their solutions evaluate in real time or periodically the expected characteristics and alert on abnormal behavior, threshold overruns, and damage.

Pubstack

Series A in 2022
Pubstack is an internet company that collects, processes, and visualize events per day. It delivers a product that customers love, they tackle and solve complex technical problems at scale, using the cloud and today’s best open source technologies.

LeddarTech

Series D in 2022
LeddarTech Inc. specializes in advanced detection and ranging systems using time-of-flight measurement technology with infrared LEDs. The company offers a range of smart sensor modules, including single-element and multi-element systems tailored for various applications, such as industrial, traffic management, and smart home solutions. LeddarTech's technology is particularly focused on enhancing advanced driver assistance systems (ADAS) and autonomous driving by providing perception solutions that integrate data from various sensor types, including cameras and radar. Their flagship platform, LeddarVision™, facilitates the creation of comprehensive 3D environmental models, addressing critical challenges in environmental sensing and perception. With over 140 patents granted or pending, LeddarTech is committed to innovation in the automotive sector, serving original equipment manufacturers (OEMs) and automotive suppliers to accelerate development cycles and improve time-to-market. Founded in 2007 and based in Quebec City, Canada, the company also maintains a research and development office in Toronto.

Secure-IC

Venture Round in 2022
Secure-IC, founded in January 2010 by researchers from Télécom ParisTech University, specializes in embedded cybersecurity solutions for connected objects and embedded systems. The company, established by Sylvain Guilley, Jean-Luc Danger, Laurent Sauvage, Hassan Triqui, and Philippe Nguyen, focuses on protecting clients from cyber-physical attacks. Secure-IC ensures that optimal security levels are achieved throughout the design process, tailored to specific vertical market applications. Its offerings are designed to safeguard sensitive datasets, providing comprehensive protection against evolving cybersecurity threats.

Aurora Cold Plasma Sterilisation

Venture Round in 2021
Aurora Cold Plasma Sterilization specializes in manufacturing medical device sterilizers that utilize cold plasma technology. The company focuses on creating sterilizers designed for the cold sterilization of fragile or complex medical devices, addressing the need for effective sterilization methods. Their devices employ low-pressure air-gas plasma generation, which enhances the safety and efficacy of sterilization processes. This innovation is particularly beneficial for protecting patients from the risks associated with non-sterilized endoscopic contamination. Aurora Cold Plasma Sterilization is backed by a network of dedicated investors, shareholders, and partners, reinforcing its position in the sterilization sector.

OceanWings

Seed Round in 2021
OceanWings is an industrial startup dedicated to reducing carbon emissions in the shipping industry by harnessing wind propulsion technology. The company specializes in designing and manufacturing the Oceanwings system, which integrates wingsails with advanced software to optimize performance. This innovative solution enables oceangoing vessels to achieve significant fuel savings, ranging from 20% to 50%, thereby lowering overall emissions. By providing an automated system that employs wing sail technology, OceanWings aims to enhance the efficiency of maritime transport and contribute to the decarbonization of the shipping sector.

Coave Therapeutics

Series B in 2021
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.

AISPRID

Venture Round in 2021
AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.

Babbar

Seed Round in 2021
Babbar is a provider of SEO services through its software-as-a-service platforms, focusing on enhancing link-building strategies based on extensive knowledge of link and page semantics. The company offers a data analytics platform that simulates search engine algorithms, allowing users to predict and analyze the positioning performance of their web pages. By utilizing advanced techniques such as backlink analysis and fine metrics, Babbar helps SEO professionals, online marketers, and webmasters improve their website performance and visibility in search engine results. Through its proprietary Babbar authority score, the company enables advertisers to gain deeper insights into their web page effectiveness, fostering a more comprehensive understanding of their digital presence.

Diafir

Venture Round in 2021
Diafir, founded in 2011 and based in Rennes, France, develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology. The company's products are designed for in situ and rapid biological analysis, with applications in point-of-care medical diagnostics, food safety, and monitoring of organic chemical reactions. By leveraging chalcogenide fiberglass, which allows for effective infrared light transmission, Diafir's systems can deliver quick and accurate diagnostic results for chronic liver diseases, infections, and tumors in as little as five minutes. This technology aims to enhance patient care by providing healthcare professionals with timely and precise information for better disease management.

dessIA

Series A in 2021
DessIA is a developer of augmented engineering software that leverages artificial intelligence to streamline product development. The company's platform assists engineers and architects by automating tasks in the early stages of design, generating numerous architectural options, and identifying optimal configurations that align with sustainability and profitability goals. By addressing complex engineering challenges, DessIA enables automotive and mechanical engineers to enhance their efficiency and explore innovative solutions, ultimately reducing lead times and increasing profit margins.

SWEETCH Energy

Venture Round in 2021
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

Velco

Venture Round in 2021
Velco SAS is a French company founded in 2015 and based in Nantes, specializing in connected cycling solutions. It designs and markets innovative handlebar devices, such as the Wink, which pairs with smartphones to enhance the cycling experience. The company's platform offers features like GPS tracking, anti-theft protection, and geofencing, aimed at improving security and performance for cyclists, e-bike brands, and fleet managers. Velco also provides a mobile application that not only tracks bike trips but also assists with navigation. By integrating these technologies, Velco aims to support mobility professionals in developing tailored connectivity solutions for the cycling market.

Velco

Venture Round in 2020
Velco SAS is a French company founded in 2015 and based in Nantes, specializing in connected cycling solutions. It designs and markets innovative handlebar devices, such as the Wink, which pairs with smartphones to enhance the cycling experience. The company's platform offers features like GPS tracking, anti-theft protection, and geofencing, aimed at improving security and performance for cyclists, e-bike brands, and fleet managers. Velco also provides a mobile application that not only tracks bike trips but also assists with navigation. By integrating these technologies, Velco aims to support mobility professionals in developing tailored connectivity solutions for the cycling market.

Niryo

Seed Round in 2020
Niryo is a provider of educational robots intended to help in prototype industrial case studies.

Nextflow Software

Series A in 2020
Nextflow Software is an independent software vendor specializing in computational fluid dynamics (CFD) and hydrodynamics. Founded in 2015 and based in Nantes, France, the company develops advanced computer-aided engineering software that provides clients with tools for accurate and efficient simulations across various industries. Its offerings include solutions for aeronautics, automotive, energy and environment, industrial processes, and marine applications, addressing specific challenges such as ditching, sloshing, dam break scenarios, and wave impact loads. The software integrates graphical tools to facilitate a comprehensive simulation and analysis workflow, helping users to streamline engineering cycles and optimize their designs.

VitaDX

Venture Round in 2020
VitaDX is a startup focused on enhancing cancer diagnosis through the application of artificial intelligence and fluorescence imaging technology. Its primary product, VisioCyt®, is designed for the early detection of bladder cancer, utilizing a simple urine sample to improve upon the traditional urinary cytology methods. By integrating machine learning with advanced imaging techniques, VitaDX aims to identify potential abnormalities in the urinary excretory tract. This innovative approach enables healthcare providers to offer more accurate and timely cancer diagnostic services, ultimately leading to improved treatment options and better patient outcomes.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

ABC Transfer

Series A in 2020
ABC Transfer is a biopharmaceutical company that develops Rapid Transfer Systems (RTS) solutions.

Quortex

Seed Round in 2020
Quortex is a developer of an AI-based video streaming service. Quortex takes OTT to the next level by bringing the latest cloud technologies to our industry.

Ecovelo

Venture Round in 2020
Ecovelo specializes in urban mobility solutions through a self-service electric bike-sharing system. Their offering includes both classic and electric bikes that can be deployed without the need for civil engineering or terminal electrification, making it suitable for cities, companies, and event promoters. The bikes are sponsored by advertisers, allowing users to generate income based on kilometers traveled and hours parked, while also displaying advertisements tailored to their geolocation. This innovative approach not only enhances mobility for individuals and small to medium-sized communities but also creates an engaging platform for advertisers.

Energiency

Series A in 2020
Energiency is SaaS platform to assess and manage energy performance industrial environment.

Aviwest

Series B in 2020
Aviwest specializes in providing advanced video contribution systems that utilize bonded unmanaged IP networks, including cellular, Wi-Fi, satellite, and public internet. The company leverages its proprietary IP bonding technology to deliver high-quality live video with optimal performance in terms of latency, power consumption, weight, and size. These solutions cater to a variety of applications, including portable, in-vehicle, and fixed locations, enabling broadcasters and video professionals to produce seamless live content. Aviwest is headquartered in Saint-Grégoire, France, and supports clients worldwide through a network of international sales offices and distribution channels in over 160 countries. The company emphasizes innovation and customer service to meet the evolving needs of its users, including broadcasters, content producers, and first responders.

Shopopop

Venture Round in 2020
Shopopop is a collaborative delivery platform for Drive races and local commerce.

Robocath

Venture Round in 2019
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in designing, developing, and commercializing robotic solutions for treating cardiovascular diseases. The company focuses on enhancing the safety and effectiveness of medical procedures through innovative robotic technology. Its flagship product, R-One™, optimizes the safety of robotic-assisted coronary angioplasty, a procedure aimed at revascularizing the cardiac muscle by inserting implants into arteries. R-One™ is engineered for precision and specific movements, improving interventional conditions for surgeons while minimizing their exposure to x-rays. With an open architecture, it is compatible with leading medical devices and catheterization laboratories. Robocath aims to become a global leader in vascular robotics, particularly in the remote treatment of vascular emergencies, ensuring optimal care pathways for patients.

Abyss Ingredients

Seed Round in 2019
Abyss Ingredients is a manufacturer of marine biotechnological ingredients aimed at promoting health and wellness across various demographics, including infants, children, and adults. Established in 2004 and headquartered in Caudan, France, with additional locations in Quimper and Lorient, the company specializes in extracting natural ingredients from sustainable marine bioresources. Its product range addresses several health concerns such as joint health, metabolic syndrome, inflammation, cardiovascular protection, digestive health, immune support, skin health, brain health, memory enhancement, sleep disorders, stress management, and muscle recovery. Abyss Ingredients focuses on innovation and sustainability, enabling nutraceutical and nutri-cosmetic companies to create effective and distinctive products that support healthy aging and overall well-being. The company serves clients both in France and internationally.

Igyxos

Series A in 2019
Igyxos S.A. is a French company based in Nouzilly that focuses on developing pharmaceuticals and medical technologies aimed at enhancing human fertility. Established in 2017, Igyxos engages in all stages of drug development, beginning with the discovery of promising targets and progressing to the identification of lead compounds, including small molecules and monoclonal antibodies. The company specializes in developing solutions that improve the efficacy of gonadotropins and hormones critical for reproduction. Igyxos also facilitates the transition of potential drug candidates through pre-clinical and clinical phases, aiming to address the increasing global demand for effective infertility treatments for both men and women.

Graftys

Series A in 2019
Graftys is an early-stage company based in Aix-en-Provence, France, specializing in advanced bone biologics. The company develops synthetic bone biomaterials specifically designed for reconstructive orthopedic surgery. Graftys offers a range of innovative and fully injectable calcium phosphate bone graft substitutes that are tailored for various clinical applications. By focusing on safety and quality, Graftys aims to provide effective solutions for patients undergoing bone reconstructive and trauma surgery.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

Biosency

Seed Round in 2019
Biosency is a medical device company based in Rennes, France, dedicated to developing innovative healthcare solutions. Its primary product is a connected PPG sensor system that offers a monitoring and prevention solution for respiratory insufficiency. This device provides continuous cardio-respiratory data, enabling healthcare professionals to prescribe respiratory assistance and manage home care effectively. By ensuring accurate measurement of patient compliance, Biosency's technology supports clinical management of respiratory diseases, ultimately enhancing patient care. The company collaborates closely with doctors and researchers to deliver advanced tools that benefit the medical community.

Monemprunt

Seed Round in 2018
Brokerage and direct exchange platform between borrowers and banks, guaranteeing a competitive and negotiated loan rate; commission & management fees less! 100% online, it shortens deadlines and cross paths, centralizes information to facilitate process and decision-making. Thought for borrowers, it provides them with the tools and advice necessary for their approach while leaving them free of their choices. In short, you have never been so ready. In 2015, they created a Credit Brokerage Company for individuals and professionals. They accompany thousands of individuals to finance their projects in the West. On a day-to-day basis, they noted the gap between the expectations and uses of "connected" young borrowers and the way banks or brokerage agencies operate. They decided to provide the monemprunt.com response, by developing new services in the form of a platform accessible 24 hours a day, for a simple, easy and intuitive approach. The loan application is managed directly by the borrowers and the team of brokers monemprunt.com negotiates the best conditions for your file.

Milestone Pharmaceuticals

Series D in 2018
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing and commercializing etripamil for various cardiovascular conditions. Etripamil is a novel short-acting calcium channel blocker designed to be administered as a rapid-onset nasal spray, specifically targeting the termination of episodes of paroxysmal supraventricular tachycardia (PSVT). The company is currently conducting Phase III clinical trials for etripamil in the treatment of PSVT and is also exploring its potential applications for atrial fibrillation, angina, and other related cardiovascular disorders. Founded in 2003, Milestone Pharmaceuticals aims to address unmet medical needs in cardiovascular disease management through innovative therapeutic solutions.

Acticor Biotech

Series B in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Shopopop

Venture Round in 2018
Shopopop is a collaborative delivery platform for Drive races and local commerce.

Velco

Venture Round in 2018
Velco SAS is a French company founded in 2015 and based in Nantes, specializing in connected cycling solutions. It designs and markets innovative handlebar devices, such as the Wink, which pairs with smartphones to enhance the cycling experience. The company's platform offers features like GPS tracking, anti-theft protection, and geofencing, aimed at improving security and performance for cyclists, e-bike brands, and fleet managers. Velco also provides a mobile application that not only tracks bike trips but also assists with navigation. By integrating these technologies, Velco aims to support mobility professionals in developing tailored connectivity solutions for the cycling market.

TRiCares

Series B in 2018
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.

ideolys

Venture Round in 2018
Ideolys SAS is a company based in La Roche sur Yon, France, specializing in web-based software solutions tailored for the catering industry. Founded in 2010, it offers Easilys, an internet application designed for managing catering operations in business and industry sectors, educational institutions, and healthcare facilities. Additionally, Ideolys provides Easilys Commandes Convives, a customer portal that facilitates remote ordering for central kitchen sites and home deliveries. The company also offers training, support, hosting, and project management services to enhance its software solutions.

Vite Mon Marché

Seed Round in 2018
Vite Mon Marché is an e-commerce company based in Marsac-sur-Don, France, specializing in the online shopping and delivery of fresh and local groceries. Founded in 2017, the company provides an on-demand service that allows customers in urban Nantes to receive deliveries of a variety of products, including fruits, vegetables, meat, fish, dairy, and beverages, often within an hour. By sourcing items directly from local producers in the Nantes area, Vite Mon Marché ensures a selection of high-quality farm produce, available every day of the week. This approach not only supports local agriculture but also caters to consumers seeking convenient access to fresh food options.

Turbotech

Venture Round in 2018
Turbotech is a French start-up specializing in the development of on-board electric generation solutions for hybrid-electric aircraft. The company has created a lightweight, compact turbo-generator that produces 55 kW of electricity by utilizing a micro-turbine to drive a high-speed generator. This innovative device can generate power from various fuel sources, including biofuels, hydrogen, and conventional fuels like Jet-A1 and gasoline, while maintaining high efficiency through a heat exchanger that captures waste exhaust heat. Additionally, Turbotech is developing a small 100 hp turboprop engine for light aircraft, which offers comparable fuel consumption to top piston engines but is lighter, quieter, and more reliable, thanks to the same heat exchanger technology. The company aims to provide efficient and eco-friendly alternatives for the aviation industry, enabling regenerative turbines for various aeronautical applications.

Biosency

Seed Round in 2018
Biosency is a medical device company based in Rennes, France, dedicated to developing innovative healthcare solutions. Its primary product is a connected PPG sensor system that offers a monitoring and prevention solution for respiratory insufficiency. This device provides continuous cardio-respiratory data, enabling healthcare professionals to prescribe respiratory assistance and manage home care effectively. By ensuring accurate measurement of patient compliance, Biosency's technology supports clinical management of respiratory diseases, ultimately enhancing patient care. The company collaborates closely with doctors and researchers to deliver advanced tools that benefit the medical community.

Blacknut

Seed Round in 2018
Blacknut is a cloud gaming service that focuses on providing a subscription-based platform for a wide audience, offering over 400 premium games suitable for the entire family. Founded in 2016 by Olivier Avaro, the company is headquartered in Rennes, France, with additional offices in Paris, Seoul, and San Francisco. Blacknut's service is available across Europe, Asia, and North America, compatible with various devices such as mobile phones, set-top boxes, and Smart TVs. The platform utilizes an algorithm to recommend games based on user preferences, allowing players to easily access and discover new titles while engaging with a community of gamers. Blacknut distributes its service directly to consumers and through partnerships with ISPs, device manufacturers, and media companies.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

BodyCap

Series A in 2017
BodyCap, an innovative company based in Hérouville Saint Clair, specializes in the development of miniaturized, wireless electronic sensors for continuous monitoring of patients' physiological variables. Its products enable healthcare professionals to gather real-time data for diagnostic and surveillance purposes, enhancing patient comfort and optimizing the information available to medical staff. BodyCap's technology is applicable in both medical and outpatient settings, making it a valuable tool for monitoring physiological conditions in various contexts, including sports and ergonomics. By focusing on continuous monitoring, BodyCap aims to improve patient care and streamline clinical investigations.

Seaver

Seed Round in 2017
Seaver is a technology startup founded in 2016 and headquartered in Ile-de-France, France. The company focuses on digitalizing the equestrian sports sector by developing innovative riding equipment that leverages the internet of things and performance monitoring. Its products enable riders and horse owners to access live streaming data on their horses' cardio, movement, and workout quality. By providing detailed insights into training and performance, Seaver supports riders in monitoring their horses' progress and health effectively.

Coave Therapeutics

Series B in 2017
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.

Milestone Pharmaceuticals

Series C in 2017
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing and commercializing etripamil for various cardiovascular conditions. Etripamil is a novel short-acting calcium channel blocker designed to be administered as a rapid-onset nasal spray, specifically targeting the termination of episodes of paroxysmal supraventricular tachycardia (PSVT). The company is currently conducting Phase III clinical trials for etripamil in the treatment of PSVT and is also exploring its potential applications for atrial fibrillation, angina, and other related cardiovascular disorders. Founded in 2003, Milestone Pharmaceuticals aims to address unmet medical needs in cardiovascular disease management through innovative therapeutic solutions.

Wexity

Seed Round in 2017
Wexity is a company that specializes in developing urban management solutions tailored for small and medium-sized cities. Founded in 2017 and based in Nantes, France, Wexity offers a digital city management platform that facilitates investment planning, growth forecasting, and risk assessment related to climate and industrial factors. The platform is designed to aid city executives in addressing the challenges posed by rapid urbanization, particularly in high-growth regions such as Africa, India, and the Middle East. By analyzing urban data, the platform monitors environmental and industrial risks, assesses impacts on infrastructure and populations, and generates comprehensive reports, thereby equipping local staff with the necessary tools to make informed decisions and enhance urban management.

Highcon

Series F in 2017
Highcon Systems Ltd specializes in the research and development of digital cutting and creasing solutions for the post-print processes in the folding carton and corrugated carton industries. The company has developed the Highcon Euclid, the first fully digital cutting and creasing machine designed for converting a variety of materials, including paper, labels, and microflute. This innovative machine utilizes Highcon’s patented Digital Adhesive Rule Technology (DART) for precise creasing and high-speed laser optics for cutting and etching. By transforming the finishing process into a value-adding operation, Highcon aims to enhance profitability for converters, printers, and brand owners by increasing speed to market, eliminating unnecessary production steps, and reducing the overall carbon footprint.

VitaDX

Seed Round in 2017
VitaDX is a startup focused on enhancing cancer diagnosis through the application of artificial intelligence and fluorescence imaging technology. Its primary product, VisioCyt®, is designed for the early detection of bladder cancer, utilizing a simple urine sample to improve upon the traditional urinary cytology methods. By integrating machine learning with advanced imaging techniques, VitaDX aims to identify potential abnormalities in the urinary excretory tract. This innovative approach enables healthcare providers to offer more accurate and timely cancer diagnostic services, ultimately leading to improved treatment options and better patient outcomes.

Robocath

Venture Round in 2017
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in designing, developing, and commercializing robotic solutions for treating cardiovascular diseases. The company focuses on enhancing the safety and effectiveness of medical procedures through innovative robotic technology. Its flagship product, R-One™, optimizes the safety of robotic-assisted coronary angioplasty, a procedure aimed at revascularizing the cardiac muscle by inserting implants into arteries. R-One™ is engineered for precision and specific movements, improving interventional conditions for surgeons while minimizing their exposure to x-rays. With an open architecture, it is compatible with leading medical devices and catheterization laboratories. Robocath aims to become a global leader in vascular robotics, particularly in the remote treatment of vascular emergencies, ensuring optimal care pathways for patients.

SWEETCH Energy

Venture Round in 2017
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

ComparateurAgricole.com

Series A in 2017
ComparateurAgricole.com aims to valorize farmers' stocks by offering the best prices in cereals (wheat, barley, corn ...) and oilseeds (rapeseed). The activity has extended to the supply of fertilizers following the demand of the farmers customers, always with the objective to guarantee the best quality / price ratio. All prices are transparent and accessible in a few clicks. The headquarters of the company is located on the family farm in GOHORY. We made the choice to stay in Beauce, granary of France, to be close to our farmers. For several months, the offices are located in Chartres, in the city of innovation, an innovative business incubator.

I-Sep

Venture Round in 2017
i-SEP is a French Medtech company focused on auto-transfusion and Patient Blood Management. The company has developed innovative technology for the separation and recovery of blood components, specifically designed for use during surgical operations. Their intraoperative blood auto-transfusers treat, concentrate, and re-transfuse a patient's own blood, allowing for the recovery of red blood cells and platelets during hemorrhagic procedures. This approach minimizes the risks associated with blood compatibility and contamination while reducing postoperative complications. By collaborating closely with surgical teams, i-SEP aims to enhance patient outcomes, streamline the workflow for medical practitioners, and lower hospital costs.

SurfactGreen

Venture Round in 2017
Surfact'Green develops, produces and markets patented ecological surfactants from agro-resources such as algae or sugar beet co-products. A business unit of the same name was created in 2011 at the Rennes National School of Chemistry (ENSCR), based on the Organic and Supramolecular Chemistry team (UMR Sciences Chimiques de Rennes), which has been working on these molecules since then. more than ten years. This business unit, supported by SATT Ouest Valorisation, has carried out works in collaboration with other public and private laboratories as well as several industrial companies interested in these surfactants.

Energiency

Series A in 2017
Energiency is SaaS platform to assess and manage energy performance industrial environment.

QOS Energy

Venture Round in 2017
QOS Energy is a software vendor based in La Chapelle sur Erdre, France, with an additional office in the United Kingdom, specializing in energy management systems. Founded in 2010, the company develops and commercializes Qantum, a cloud-based Software-as-a-Service platform designed for the monitoring and management of renewable energy infrastructures. Qantum serves the needs of professional energy performance managers, optimizing the operational performance of over 3,500 sites globally, including various renewable energy plants such as photovoltaic, wind, hydraulic, and biogas facilities, as well as energy efficiency projects in buildings and smart grid initiatives. As a subsidiary of The Astelia Group, QOS Energy focuses on enhancing energy management capabilities across Europe and beyond.

Malkyrs

Venture Round in 2016
Malkyrs Studio SAS, established in 2015 and headquartered in Caen, France, specializes in the development of online card games that blend traditional gameplay with digital enhancements. The company focuses on creating unique gaming experiences by integrating elements of physical card games with the advantages of online interaction. Malkyrs Studio aims to engage players through theme-based games that feature high-definition graphics and characters inspired by mythology and ancient stories, offering a modern twist on classic card game mechanics.

EasyBroadcast

Seed Round in 2016
EasyBroadcast is a technology startup focused on addressing critical challenges in over-the-top (OTT) video streaming, particularly high distribution costs and quality issues such as latency and startup time. The company offers an end-to-end streaming solution that allows broadcasters, TV channels, and other content providers to deliver high-quality audio and video over the internet or private networks. Its patented technology empowers viewers to assist in content delivery by streaming segments they are currently watching to others, which enhances streaming quality and reduces reliance on traditional content delivery networks. This innovative approach not only lowers infrastructure costs but also improves viewer satisfaction and engagement, enabling broadcasters and enterprises to effectively monetize their content through custom advertising and reach a wider audience across various devices.

Sabella

Venture Round in 2016
Sabella is a developer of marine current turbines that provides reliable energy solutions globally. The company offers a range of innovative and economically optimized technologies, supported by patents, to promote sustainable energy models tailored for remote grids, particularly in islands and isolated coastal communities. In addition to its turbine technology, Sabella also delivers engineering and project management services to facilitate the installation of its systems, allowing clients to transition to sustainable energy with ease.

Kemwatt SAS

Private Equity Round in 2016
Kemwatt SAS designs, develops, manufactures, and markets batteries with circulating electrolytes for application in stationary storage of electricity to facilitate the management of the network within the framework of renewable electrical production.

Dictanova

Venture Round in 2016
Dictanova is a software as a service company founded in 2011 and based in Nantes, France. It specializes in text analytics and sentiment analysis, providing a cloud-based platform that helps businesses understand customer feedback. The platform is designed for marketing and customer experience professionals, enabling them to quickly analyze thousands of client comments from satisfaction surveys. By utilizing advanced technologies such as artificial intelligence and machine learning, Dictanova's semantic analysis engine allows companies to identify customer needs, uncover areas of tension in the customer experience, and recognize factors that enhance customer satisfaction. In 2019, Dictanova became a subsidiary of Easiware SAS.

I-Sep

Seed Round in 2015
i-SEP is a French Medtech company focused on auto-transfusion and Patient Blood Management. The company has developed innovative technology for the separation and recovery of blood components, specifically designed for use during surgical operations. Their intraoperative blood auto-transfusers treat, concentrate, and re-transfuse a patient's own blood, allowing for the recovery of red blood cells and platelets during hemorrhagic procedures. This approach minimizes the risks associated with blood compatibility and contamination while reducing postoperative complications. By collaborating closely with surgical teams, i-SEP aims to enhance patient outcomes, streamline the workflow for medical practitioners, and lower hospital costs.

Ergosup

Series A in 2015
Ergosup developes an innovative process for producing high pressure hydrogen on site for refueling hydrogen fuel vehicles.

Qowisio

Venture Round in 2015
Qowisio is a global leader that dedicates to low cost and low power cellular network for the IoT (LPWAN). It offers a wide range of connected devices and technological bricks in order to address new use cases for SMBs and blue-chip customers. The company’s products are used in fuel tank monitoring and power metering applications. Qowisio is a France-based company that was founded in 2009.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.